Biotech's Biggest Players: Amgen, Biogen and Genentech

Author：

ISSN： 1537-1328

Source： Pharmaceutical Innovation, Vol.12, Iss.1, 2002-12, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Britain's Biggest Biotech Battling for Blockbuster - Celltech's Fortunes Tied to CDP870

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 3, 2004-06 ,pp. : 35-38

Adis International

Access to resources Recommend Favorite

Boom in sales expected in 2003 by Bayer, Genentech

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cinacalcet: Amg 073, Calcimimetics - Amgen/NPS Pharmaceuticals

Drugs in R&D, Vol. 4, Iss. 1, 2003-01 ,pp. : 39-41

Adis International

Access to resources Recommend Favorite

Update on biotech drugs for psoriasis

Inpharma, Vol. 1, Iss. 1297, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

The filing for US FDA approval of efalizumab [`Xanelim'; Genentech, XOMA] may be delayed

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite